Provided by MZ Data Products
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of November, 2005

(Commission File No. 1-14862 )
 

 
BRASKEM S.A.
(Exact Name as Specified in its Charter)
 
N/A
(Translation of registrant's name into English)
 


Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil
(Address of principal executive offices)



Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.



 

Earnings Release Events

Investor Relations Meetings

In São Paulo:
November 22, 2005, at 8:30 a.m. (Brazilian Official Time)

In Rio de Janeiro:
November 25., at 8:30 a.m..
(Brazilian Official Time)

Brazilian Conference Call:
November 11, 2005,
at 7:00 a.m. US EST
(10:00 a.m. Brazil)

International Conference Call:
November 11, 2005,
at 9:00 a.m. US EST
(12:00 p.m. Brazil).

Further information is available on Braskem´s IR website at www.braskem.com.br/ir or by contacting our IR Team:

José Marcos Treiger
IRO
Tel: (+55 11) 3443 9529 jm.treiger@braskem.com.br

Luiz Henrique Valverde
IR Manager
Tel: (+55 11) 3443 9744 luiz.valverde@braskem.com.br

Luciana Ferreira
IR Manager
Tel: (+55 11) 3443 9178

 

Year-to-date Net Income reaches R$681 million
Thermoplastic resins sales increased 18% in the quarter

São Paulo, November 9, 2005- BRASKEM S.A. (BOVESPA: BRKM5; NYSE:BAK; LATIBEX:XBRK), leader in the thermoplastic resins segment in Latin America and one of the three largest Brazilian privately-owned industrial companies, announced today its results for the third quarter of 2005 (3Q05) and for the nine months ended September 30, 2005 (9M05).

Results are stated in accordance with the Brazilian Corporate Law, except that the results presented herein are not in accordance with CVM Instruction 247 as they exclude the effects of proportional consolidation. The comments in this release refer to the consolidated earnings with all comparisons being made with the same period in 2004, except where otherwise indicated. The consolidated balance sheet and income statements have been reviewed by independent auditors and also reflect the elimination of the effects of CVM Instruction 247 (i.e., only those investments under Braskem’s direct management are consolidated, and Braskem’s stakes in Politeno Indústria e Comércio S.A., COPESUL – Companhia Petroquímica do Sul and Petroflex Indústria e Comércio S.A. are recognized through the equity accounting method). On September 30, 2005, the Brazilian Real/ U.S. dollar exchange rate was R$ 2.2222/US$ 1.00.


1. Highlights of the Quarter
  • In the first nine months of 2005, the production of thermoplastic resins (PE, PP and PVC) grew by 10% compared to the same period in 2004, maintaining high capacity utilization rates. This performance confirms the Company’s operational excellence.
  • Braskem has been accelerating the capture of productivity gains from “Braskem +”, its operational excellence and business competitiveness program, which should allow it to move forward the conclusion date of the program, originally scheduled for the end of 2007. Since the start of this program through September 2005, the Company has captured R$235 million in productivity gains, on an annual and recurring basis. This figure already exceeds the targets set for the end of 2005 by R$65 million.
  • In 3Q05, total sales volumes of thermoplastic resins grew by 18% compared to the second quarter of 2005. This increase was concentrated in the domestic market, in which demand has increased since the beginning of September 2005T. Total sales volumes increased by 10% during 3Q05, led by polypropylene sales volumes, which increased by 14% during this period. During the 9M05, thermoplastic resin sales increased by 8% compared to 9M04.
  • Exports achieved a record performance during the 9M05, reaching US$739 million, a 21% increase compared to the US$612 million recorded during the same period in 2004. This increase demonstrates Braskem’s strategic flexibility in the domestic and exports markets.
  • When expressed in U.S. dollars, Braskem’s net revenue increased by 27% during the 9M05, totaling US$3.5 billion. When expressed in reais, Braskem’s net revenue increased by 6% during the same period, reaching R$8.8 billion.
  • In mid-September 2005, the price for naphtha, our main raw material, reached US$600/ton, the highest price ever recorded. The average ARA (Amsterdam – Rotterdam - Antwerp) price of naphtha during the third quarter of 2005 was US$522/ton. This represented an 18% increase compared to the second quarter of 2005 and a 29% increase compared to 3Q04, when the average price was US$405/ton. During the 9M05, the ARA price of naphtha also increased by 29%.
  • Although naphtha prices were 29% higher when expressed in U.S. dollars during the 9M05, Braskem’s EBITDA reached US$639 million in 9M05, a 1% increase compared to the same period in 2004. In reais, EBITDA reached R$1.6 billion, a 15% decrease compared to the R$1.9 billion recorded during the same period in 2004, proving the impact of the exchange rate trajectory on our results.

2





3


2. Operating Performance

Braskem maintained high capacity utilization rates, with capacity utilization rates for PP production of 97%, PE production of 96% and PVC production of 95%. These high capacity utilization rates confirm the operational excellence achieved by Braskem, as shown by improvements in the operational reliability of its plants and the efficient utilization of new production capacity added throughout 2004.

*Includes additional production capacity of 100,000 tons/year added as of July 2004. From 2006 onward, an
additional 30,000 tons will be added to this capacity.

Consequently, Braskem recorded increases in its production volumes of thermoplastic resins of 4% during the 3Q05 and 10% during the 9M05. However, there was a decrease in production at the Basic Petrochemicals Business Unit due to operating problems experienced by some of Braskem’s propylene customers, which reduced the capacity utilization rate and thus the production of ethylene, propylene and their derivatives.

 Production Volume - tons    3Q05    2Q05    3Q04    Var. %    Var. %    9M05    9M04    Var. % 
    (A)   (B)    (C)   (A)/(B)   (A)/(C)    (D)    (E)   (D)/(E)
 
Polyolefins Unit                                 
   . PE´s - Polyethylene    200,445    191,839    195,764    4    2    587,466    542,192    8 
   . PP - Polypropylene    136,308    135,639    123,359    0    10    395,923    342,253    16 
   . Total (PE´s + PP)   336,752    327,478    319,123    3    6    983,389    884,445    11 
 
Vinyls Unit                                 
   . PVC - Polyvinyl Chloride    113,671    112,723    113,029    1    1    339,870    316,082    8 
   . Caustic Soda    111,983    112,749    122,526    (1)    (9)   349,889    339,340    3 
 
Basic Petrochemicals Unit                                 
   . Ethylene    285,214    295,188    303,557    (3)    (6)   876,081    811,157    8 
   . Propylene    142,345    138,134    149,379    3     (5)   419,042    398,058    5 
 
Business Development Unit                                 
   . PET    19,465    12,353    17,376    58    12    49,471    53,636     (8)
   . Caprolactam    14,031    14,897    13,913    (6)   1    42,222    38,600    9 
                 

4


Total sales volumes of Braskem’s main products increased by 6% during the 3Q05 compared to the second quarter of 2005, positively impacted by domestic sales. Thermoplastic resins domestic sales increased by 22% during the 3Q05 compared to the second quarter of 2005, in line with the increase in the size of the Brazilian market during the same period. Compared to the third quarter of 2004, there was a 2% increase in sales volumes, primarily due to higher sales of polypropylene.

Sales Volume - tons    3Q05    2Q05    3Q04    Var. %    Var. %    9M05    9M04    Var. % 
    (A)   (B)    (C)   (A)/(B)   (A)/(C)    (D)    (E)   (D)/(E)
 
Polyolefins Unit                                 
 . PE´s - Polyethylene    210,145    179,580    194,529    17      593,560    539,161    10 
 . PP - Polypropylene    148,871    116,900    130,085    27    14    396,339    354,472    12 
 . Total (PE´s + PP)   359,016    296,480    324,614    21    11    989,898    893,632    11 
 
Vinyls Unit                                 
 . PVC - Polyvinyl Chloride    127,050    114,751    115,665    11    10    337,377    332,147   
 . Caustic Soda    115,583    108,829    116,041        343,550    331,038   
 
Basic Petrochemical Unit                                 
 . Ethylene*    291,418    297,047    305,214    (2)   (5)   879,433    804,000   
 . Propylene*    128,304    151,071    145,676    (15)   (12)   416,117    398,035   
 
Business Development Unit                                 
 . PET    22,651    10,836    17,482    109    30    49,602    55,490    (11)
 . Caprolactam    11,953    15,124    14,009    (21)   (15)   40,605    38,610   
                 

*Includes sales/transfers of ethylene and propylene (tons) to Braskem’s other Business Units.

The Polyolefins Business Unit recorded a 6% production increase in the third quarter of 2005 compared to the same period in 2004, and a 3% increase as compared to the second quarter of 2005.

As a result of the production capacity increases implemented at the end of 2004, during the 3Q05, sales volumes of PE and PP by the Polyolefins Business Unit increased by 11% compared to the same period in 2004. This increase in PE and PP sales volumes during the 3Q05 was primarily driven by domestic market sales, which increased by 23% compared to the same period in 2004. During the 9M05, sales volumes of PE and PP also increased by 11% compared to the same period in 2004. It is worth noting the important role of exports, which increased by 70% during the 9M05.

In the Vinyls Business Unit, the highlight was PVC capacity utilization rates, which have remained above 95% since early 2005.

PVC sales increased by 11% during the 3Q05 compared to the second quarter of 2005 and increased by 10% compared to the same period in 2004. A trend of higher domestic sales volumes of PVC was noted during September 2005, which could indicate a recovery in the civil construction sector that had shown weak performance until then.

The Basic Petrochemicals Unit recorded capacity utilization rates of 91% during the 9M05, in line with the capacity utilization rates recorded during the same period in 2004. The capacity utilization rates during the 3Q05, however, decreased compared to the second quarter of 2005 for the reasons explained before.

In relation to the Unit’s commercial performance, there was, consequently, a reduction in sales volumes of olefins, especially of propylene, which decreased by 15% compared to the second quarter of 2005, and by 12% compared to the third quarter of 2004.

The Business Development Unit recorded a 109% increase in PET sales during the 3Q05, compared to the second quarter of 2005 (during which, demand was considerably lower than the average for the period), and a 30% increase compared to the third quarter of 2004. During the 9M05, PET sales decreased by 11% compared to the same period in 2004, due to decreased demand observed during the first half of 2005.

5


3. Braskem Management Systems

3.1 Business Competitiveness:

Braskem continues the implementation of its operational excellence and business competitiveness program, called “Braskem +.” The implementation teams for this important program, designed to increase business competitiveness and productivity levels, continued to achieve higher results than those initially estimated for the 3Q05. By September 2005, Braskem had already captured, on an annual and recurring basis, R$235 million in productivity gains, outperforming the estimated R$170 million planned to be captured by December, 2005. In terms of the amount of productivity gains expected to be captured by September 30, 2005, the actual results outperformed the projections by 48%.

3.2 Fórmula Braskem

Braskem has launched a new project to implement an integrated management system, “Fórmula Braskem”. This program will define the methodologies and tools that will drive the Company’s growth over the next few years, through a restructuring of its processes. The development of a new integrated management system is consistent with Braskem’s value creation strategy, as it is expected to generate efficiency and productivity gains. Its adoption will also facilitate the monitoring of compliance with the Sarbanes-Oxley Act and rules promulgated thereunder, which is consistent with Braskem’s commitment to transparent management and corporate governance.

The decision to adopt the SAP technology took into account the fact that Braskem will be a key global partner with its supplier, which is the world leader in the sector. This status will grant Braskem access to the best practices adopted by the international petrochemical industry in management systems. Braskem plans to invest approximately R$130 million in this project, with a net present value estimated at R$260 million.

4. Financial and Economic Performance

4.1. Net Revenue

Braskem’s sales policy is designed to align permanently domestic prices for its products with those prevailing in the international markets. Consistent with this policy, the Company adjusted its service margins to market reality during the 3Q05, with an approximate 11% reduction in its average prices, in reais, compared to prices during the second quarter of 2005. As of September 2005, Braskem’s price levels were already approximately 6% higher than in June 2005, when expressed in U.S. dollars. During the 9M05, the Company’s thermoplastic resin prices were 22% higher than the same in 2004, when expressed in U.S. dollars.

Braskem’s net revenue during the 3Q05 was R$2.8 billion, 17% lower than the R$3.4 billion recorded during the same period in 2004. This decrease in net revenue is due to the price alignment mentioned above, as well as to the effects of the exchange rate variation (average exchange rate of R$2.343 during the 3Q05 compared to R$2.978 during the same period in 2004) in the translation of U.S. dollar prices into reais. During the 9M05, Braskem’s net revenue reached R$8.8 billion, a 6% increase compared to the same period of 2004.


6


4.1.1 Exports

Braskem maintains long-term commercial relationships with strategic international clients in attractive markets. The Company has been developing new commercial practices that aim at establishing a direct relationship with a larger number of end clients abroad. Towards this end, Braskem has been seeking closer ties to these clients and has used specialized traders. As part of this strategy, the Company intends to establish a subsidiary in Argentina in order to perform direct sales to its client in the region.

Due to better domestic market performance and to the 5.5% appreciation of the real against the U.S. dollar, Braskem’s net export revenue totaled US$230 million during the 3Q05, 7% lower than net export revenue during the second quarter of 2005. Braskem continues exporting approximately 19% of its net revenue in 3Q05; it is worth pointing out that exports to South America, with lower logistics costs compared to other destinations, increased from 15% during the third quarter of 2005 to 19% during the 3Q05.

4.2. Cost of Goods Sold (COGS)

During the third quarter of 2005, Braskem’s cost of goods sold (COGS) totaled R$2,398 million, which represented an increase of 6% compared to the second quarter of 2005, and an 8% decrease compared to the third quarter of 2004. COGS increased by 11% during the 9M05, compared to the same period in 2004. This increase was primarily due to a rise in raw material costs. The average price of naphtha ARA (Amsterdam – Rotterdam - Antwerp) was US$522/ton during 3Q05, which represented a 29% increase compared to US$405/ton recorded during the same period in 2004. During the 9M05, the average ARA price of naphtha also increased by 29% compared to the same period in 2004. It is worth pointing out that in mid-September 2005, naphtha ARA reached US$600/ton, the highest price ever recorded. The 5.5% appreciation in the value of the real against the U.S. dollar during the 9M05 substantially offset such price increase. In respect to ethylene and propylene acquired from Copesul, the increase in costs during the 3Q05 was 7%, or R$26 million, compared with the second quarter of 2005, due to the effect of the increase in naphtha on the pricing formula of these products, which are set based on the margin sharing system.

7


During the third quarter of 2005 (and the second quarter of 2005), Braskem acquired approximately 1.1 million tons of naphtha, out of which 828 thousand tons (75%) were acquired in the domestic market. The remaining 272 thousand tons (25%) were imported directly by the Company, primarily from countries in North Africa and the Middle East.

Depreciation and amortization expenses during the third quarter of 2005 totaled R$102 million, a 3% increase compared to the R$99 million recorded during the same period in 2004. This increase was due primarily to investments in capacity increases undertaken in 2004.

4.3. Selling, General and Administrative Expenses (SG&A)

Braskem’s SG&A expenses totaled R$169 million during the third quarter of 2005, in line with the second quarter of 2005. During the 9M05, SG&A totaled R$514 million, compared to R$365 million during the same period of 2004. The increase in SG&A expenses during the 9M05 derives from increased selling expenses due to higher sales volume, increased personnel expenses due to annual salary adjustments made during the second half of 2004 and an increase in the provision for Profit Sharing.

4.4. Depreciation and Amortization Expenses

Depreciation and amortization expenses totaled R$75 million during the third quarter of 2005, a 10% decrease compared to the R$85 million recorded during the same period in 2004, and R$23 million lower than 2Q05, as a consequence of the full amortization of expenses related to structured finance transactions undertaken during this period.

During the 9M05, these expenses reached R$270 million, representing an increase of R$30 million compared to the same period in 2004, also as a result of the full amortization of the above-mentioned expenses.

4.5. EBITDA

Braskem’s EBITDA reached R$353 million during the third quarter of 2005, R$744 million lower than EBITDA recorded during the same period in 2004. When expressed in U.S dollars, Braskem’s EBITDA

8


reached US$150 million during the third quarter of 2005 compared to the US$250 million recorded during the same period in 2004. These decreases are primarily the result of an increase in naphtha prices and the impact of the appreciation of the real on the Company’s revenue and costs.

Compared to the second quarter of 2005, EBITDA in US dollars was 35% lower, reflecting the increase in naphtha prices, the alignment of domestic market prices to the reality of international prices and the appreciation of the real.

During the 9M05, EBITDA expressed in U.S. dollars increased by 1%, despite the 29% increase in the price of naphtha. Braskem’s results of operations, when expressed in U.S. dollars, provide a more accurate measure of the Company’s performance, as the Company’s revenue is linked to the U.S. dollar to the extent that its domestic prices are aligned with international market prices and as approximately 80% of the Company’s costs are linked to the U.S. dollar.

4.6. Investments in Subsidiaries and Associated Companies

Excluding the effects of the amortization of goodwill primarily arising from investments in Copesul, Politeno and Petroflex, Braskem recorded net income of R$43 million from its investments in subsidiaries and associated companies during the third quarter of 2005, compared to R$87 million recorded during the same period in 2004. This decrease reflects the lower results recorded by its subsidiaries, as a consequence of an imbalance between prices for raw material and prices for their final products. During the 9M05, net income from Braskem’s investments in subsidiaries and associated companies totaled R$198 million, a 13% increase compared to the same period in 2004 (excluding the same effects as above). During the 3Q05, the results of Braskem’s principal affiliated companies, Copesul, Politeno and Petroflex, taking into consideration its percentage interest in these companies as of September 30, 2005 (29.5%, 34% and 20%, respectively), totaled R$42 million compared to R$74 million recorded during the same period in 2004.

3Q05 Equity results from Petroflex include only July and August.

The principal indicators of the results of these companies are shown in the table below:

9


(R$ thousand)                    
Investments in Subsidiaries and    3Q05    2Q05    3Q04     9M05    9M04 
Affiliated Companies                     
 
Subsidaries - Equity Method    543    1,561    2,962    (2,992)   3,373 
Affiliated Companies - Equity Method    41,874    59,068    74,496    189,796    175,712 
. Copesul    37,212    43,603    54,538    144,738    127,102 
. Politeno    5,364    7,711    15,222    26,187    34,188 
. Others    702    7,753    4,736    18,871    14,422 
Exchange Variation    908    17,276    8,420    12,549    (6,207)
   Others    (68)    (1,263)   1,275    (869)   2,942 
     Subtotal (before amortization)   43,258    76,642    87,154    198,485    175,820 
Goodwill Amortization    (38,144)   (38,211)   (38,174)   (114,279)   (114,545)
 
           
TOTAL    5,114    38,431    48,979    84,207    61,275 
           

Main Subsidiaries - 3Q05    Copesul    Politeno 
R$ million         
Net Revenue    1,423    289 
EBITDA    245    23 
EBITDA Margin (%)   17   
Net Profit (Loss)   129    12 


4.7. Net Financial Result

Excluding the effects of monetary and exchange rate variations, Braskem’s net financial result during the third quarter of 2005 was an expense of R$151 million, representing a 27% decrease compared to an expense of R$207 million recorded during the same period of 2004. During the 9M05, Braskem’s net financial result was an expense of R$497 million, a 25% decrease compared to the same period in 2004.

The improved net financial result is mainly observed in the provision for interest expenses, reflecting an effective reduction in the amount of consolidated debt, denominated in reais, particularly in respect to more costly debt agreements, which resulted in the reduction of the Company’s cost of capital. Financial expenses related to interest and obligations to vendors decreased significantly, from R$146 million during the third quarter of 2004 to R$108 million during the third quarter of 2005.

The exchange rate variations during the third quarter of 2005 was R$92 million compared to R$368 million during the second quarter of 2005, primarily due to the lower net exposure to exchange rate variations and the lower rate of appreciation of the real during the 3Q05: 5.5% in 3Q05 compared to 11.8% in the second quarter of 2005.

There has also been a significant improvement in terms of the interest coverage ratio, as the EBITDA/Interest Expense ratio increased from 3.7 times in 2004 to 5.8 times during the 9M05. The slight reduction in this ratio to 5.6 times during the first half of 2005 is due to the reduction in EBITDA during the 3Q05, as explained above.

10


(R$ million)                    
    3Q05    2Q05    3Q04    9M05    9M04 
Financial Expenses    (8)   350    150    58    (1,069)
                   Interest / Vendor    (104)   (108)   (146)   (335)   (496)
                   Monetary Restatement    (59)   (66)   (113)   (178)   (323)
                   F/X on Liabilities    241    604    502    820    8 
                   CPMF/IOF/Income Tax/Banking Expe    (25)   (27)   (33)   (77)   (100)
                   Other    (61)   (53)   (58)   (173)   (158)
Financial Revenue    (108)   (213)   (185)   (281)   (52)
                   Interest    39    20    31    87    87 
                   Monetary Restatement    2    3    2    9    13 
                   F/X on Assets    (149)   (236)   (218)   (377)   (151)
 
           
Net Financial Result    (116)   137    (35)   (223)   (1,121)
                     
           

(R$ million)                    
    3Q05    2Q05    3Q04    9M05    9M04 
                     
Net Financial Result    (116)   137    (35)   (223)   (1,121)
                     
           
                     
Foreign Exchange Gain Variation (F/X)   92    368    284    443    (144)
Monetary Restatement (MR)   (57)   (64)   (111)   (169)   (310)
                     
           
Financial Result less F/X and MR    (151)   (168)   (207)   (497)   (667)
 

4.8. Net Income

Braskem recorded net income of R$48 million during the third quarter of 2005, compared to net income of R$496 million recorded during the same period in 2004, and R$428 million observed during the second quarter of 2005. This result reflects the points mentioned above. For the first nine months of 2005, net income reached R$ 681 million, a 234% increase compared to the R$ 204 million recorded during the same period in 2004.

4.9. Free Cash Flow

Consistent with its good operating performance and strong cash generation from operations, Braskem’s free cash flow reached R$ 801 millions during the 9M05, a 38% increase compared to the R$579 million generated during the same period in 2004.

In the 3Q05, Braskem amortized R$ 492 million in amounts due to suppliers of imported naphtha, impactiing its operating cash flow. These payments are reflected in the net variation in the account Suppliers, between the second and third quarters of 2005, in the amount of R$ 280 million.

R$ million    3Q05    2Q05    3Q04    9M04    9M05 
                     
Operating Cash flow    77    804    818    1,739    1,650 
                     
Interest Paid    (101)   (89)   (189)   (513)   (219)
Investment Activities    (314)   (193)   (185)   (647)   (630)
                     
Free Cash Flow    (339)   522    443    579    801 
                     
Taxes Paid    (15)     (6)   (9)   (30)
           

11


4.10 – Capital Structure and Liquidity

Braskem has been prioritizing the reduction of its cost of capital and the extension of its average debt maturity. Therefore, Braskem has managed to increase the average maturity of its debt to 9.8 years and to reduce its cost of capital to approximately US$+ 6% p.a., while still maintaining high levels of cash and cash equivalents, in order to provide greater operational, financial and strategic flexibility. Braskem’s net cash balance decreased by R$ 877 million during the 3Q05 compared to the second quarter of 2005, due to the high level of amortizations and investments made during the 3Q05.

Braskem’s net debt at the end of the third quarter of 2005 was R$3,115 million, which represented a decrease of 20% when compared to the end of 2004 (R$3,868 million) and of 35% when compared to the same period in 2004 (R$4,759 million). When expressed in U.S. dollars, Braskem’s net debt decreased by 4%, from US$1.5 billion as of December 31, 2004, to US$ 1.4 billion as of September 30, 2005.

Braskem’s level of financial leverage, measured by the Net Debt/EBITDA ratio, decreased by 10% during the 9M05, from 1.52 as of December 31, 2004 to 1.37 as of September 30, 2005.

The graph below shows Braskem’s amortization schedule at the end of the third quarter of 2005:


12


Additionally, the debt profile by category and index is shown below:


5. Capital Expenditures

From January to September 2005, Braskem invested R$428 million in important programs to increase its production capacity, to achieve productivity and efficiency gains, to upgrade technology and to invest in the Health, Safety and Environmental areas. The capacity increases (through debottlenecking) were focused on PE and PVC production. Regarding PE production capacity, 30,000 tons of capacity was added during September 2005, and 30,000 tons in additional production capacity are expected to be added by the first quarter of 2006. Through the end of the 3Q05, Braskem has invested a total of R$ 9 million in these two PE projects. In respect of PVC, 50,000 tons of additional production capacity are expected to be effective as of November 2005, and the amount invested on this project through September 2005 totaled R$ 65 million. This total investment of R$ 74 million is included in the total amount detailed above.

This total amount also includes the first disbursement of R$ 8 million for a project to build a modern and competitive new plant in Paulínia – in the State of São Paulo - that will produce and sell polypropylene in partnership with Petroquisa, as announced on June 22, 2005. .

In addition, deferred expenses incurred during planned maintenance stoppages amounted to R$90 million. The total amount to be invested through the end of 2005 is estimated at R$ 600 million.

6. Capital Markets and Investor Relations

In September 2005, Braskem (BRKM5) reached 10th place in Bovespa’s four-month theoretical portfolio, increasing from 1.3% to 2.7% of this index, more than doubling its share in one year. Braskem is also included in the IBrX-50 index, with a 1.1% share, and in the IGC (Corporate Governance Index), with a 1.7% share. The Company also more than doubled its number of total investors since its creation, from 4,922 in August 2002, to 15,770 investors in September 2005.

13



The table below shows the performance of Braskem’s securities during the periods presented:

Stock Performance - BRKM5    09/30/04    12/31/04    03/31/05    06/30/05    09/30/05 
Closing Price (R$ per thousand shares)   23.40    32.94    27.07    19.55    22.99 
Return in the Quarter (%)   68.5    40.8    (17.8)   (27.8)   17.6 
Accumulated Return (%)*    765    1,118    901    623    750 
Bovespa Index Accumulated Return (%)*    106    132    136    122    180 
Average Daily Trading Volume (R$ thousand)   16,016    21,618    30,078    23,262    31,059 
Market Capitalization (R$ million)   8,426    11,925    9,802    7,078    8,324 
Market Capitalization (US$ million)   2,948    4,493    3,676    3,011    3,746 
ADR Performance - BAK    09/30/04    12/31/04    03/31/05    06/30/05    09/30/05 
Closing Price (R$ per ADR)   16.54    25.48    20.25    16.78    20.72 
Return in the Quarter (%)   79.2    53.1    (20.5)   (17.1)   23.5 
Accumulated Return (%)*    902    1,444    1,127    917    1,156 
Average Daily Trading Volume (US$ thousand)   1,711    3,646    5,221    3,826    4,934 
Other Information    09/30/04    12/31/04    03/31/05    06/30/05    09/30/05 
Total Number of Shares (million)   362,579    362,543    362,524    362,524    362,524 
           
. Common Shares (ON) - BRKM3    120,860    120,860    120,860    120,860    120,860 
           
. Preferred Shares Class "A" (PNA) - BRKM5    240,805    240,840    240,860    240,860    240,860 
           
. Preferred Shares Class "B" (PNB)   914    843    803    803    803 
           
 (-) Shares in Treasury (PNA) - BRKM5    (2,488)   (467)   (467)   (467)   (467)
           
= Total Number of Shares (ex Treasury)   360,092    362,076    362,056    362,056    362,056 
           
ADR (American Depositary Receipt )                    
 
* Accumulated return since the market closing on December 30, 2002.    1 ADR = 2 shares BRKM5         
 
Source: Economática/Braskem                     
 

By the end of October 2005, Braskem’s ADR program achieved an important milestone, as its trading volume at the New York Stock Exchange (NYSE) reached US$1 billion, consolidating its position as one of the top 20 Brazilian ADR programs listed at the NYSE in terms of liquidity in 2005.

14


7. Recent Events

At the beginnning of November, Standard&Poor’s (S&P) reviewed Braskem’s ratings within its ‘Global Scale - foreign currency’ and its ‘National Scale for Brazil’. At the ‘Global Scale - foreign currency’, the Company moved up to BB from a BB- rating, placing itself one notch above the rating for the Brazil Federative Republic, which remains BB-. At the ‘National Scale for Brazil’, the change was from a rating of ‘brAA- stable outlook’ to ‘positive outlook’, based on positive estimates to Braskem, in the medium term, regarding its capital structure, liquidity and resilience to the petrochemical cycle.

15



8. List of Exhibits


    Page 
EXHIBIT I – Consolidated Income Statement    17 
     
EXHIBIT II – Consolidated Balance Sheet    18 
     
EXHIBIT III – Consolidated Cash Flow    19 
     
EXHIBIT IV – Net Revenue by Business Unit    20 

 


Braskem, a world-class Brazilian petrochemical company, is the leader in the thermoplastic resins segment in Latin American, and is among the three largest Brazilian privately-owned industrial companies. The company operates 13 manufacturing plants located throughout Brazil, and it has an annual production capacity of approximately 5.8 million tons of petrochemical products . 

x x x

FORWARD-LOOKING STATEMENT DISCLAIMER

This press release contains statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements are only predictions and are not guarantees of future performance. Investors are cautioned that any such forward-looking statements are and will be, as the case may be, subject to many risks, uncertainties and factors relating to the operations and business environments of Braskem and its subsidiaries that may cause the actual results of the companies to be materially different from any future results expressed or implied in such forward-looking statements.

Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, the risks and uncertainties set forth from time to time in Braskem's reports filed with the United States Securities and Exchange Commission. Although Braskem believes that the expectations and assumptions reflected in the forward-looking statements are reasonable based on information currently available to Braskem’s management, Braskem cannot guarantee future results or events. Braskem expressly disclaims a duty to update any of the forward-looking statements.

16


     EXHIBIT I

Braskem S.A.
Consolidated Income Statement(1)
(R$ million)

    3Q05    2Q05    3Q04   Var. (%)   Var (%)   9M05    9M04    Var.(%)
Income Statement     (A)    (B)   (C)   (A)/(B)   (A)/(C)    (C)    (D)   (C)/(D)
                 
Gross revenue    3,680    3,788    4,335    (3)   (15)   11,464    10,595   
Net revenue    2,798    2,885    3,362    (3)   (17)   8,759    8,246   
Cost of goods sold    (2,398)   (2,264)   (2,599)     (8)   (6,982)   (6,297)   11 
Gross profit    400    621    764    (36)   (48)   1,777    1,949    (9)
Selling expenses    (56)   (61)   (49)   (7)   15    (175)   (147)   19 
General and Administrative expenses    (113)   (116)   (75)   (3)   49    (339)   (218)   56 
Depreciation and amortization    (75)   (98)   (85)   (23)   (12)   (270)   (240)   12 
Other operating income (expenses)   19    12      60    288    38    32    18 
Investments in Affiliated Companies      38    49    (87)   (90)   84    61    37 
    .Equity Result    43    77    87    (44)   (50)   198    176    13 
    .Amortization of goodwill/negative goodwill    (38)   (38)   (38)       (114)   (115)  
Operating profit before financial result    180    397    608    (55)   (70)   1,116    1,437    (22)
Net operating result    (116)   137    (35)     231    (223)   (1,121)   (80)
Operating profit (loss)   65    533    573    (88)   (89)   893    316    183 
Other non-operating revenue (expenses)     (4)   (2)       (17)   (3)   415 
Profit (loss) before income tax and social
    contribution
 
  65    530    571    (88)   (89)   876    313    180 
Income tax / social contribution    (18)   (105)   (70)   (83)   (75)   (194)   (91)   113 
Profit (loss) before minority interest    47    425    501    (89)   (91)   682    222    208 
Minority Interest        (5)       (1)   (17)   (96)
Net profit (loss)   48    428    496    (89)   (90)   681    204    233 
                 
EBITDA    353    570    744    (38)   (53)   1,610    1,888    (15)
EBITDA Margin    12.6%    19.8%    22.1%    -7.2 p.p.   -9.5 p.p.    18.4%    22.9%   -4.5 p.p. 
-Depreciacion and Amortization    177    212    184    (16)   (4)   579    513    13 
   . Cost    102    114    99    (10)     309    272    14 
   . Expense    75    98    85    (23)   (12)   270    240    12 
                 
1-Excludes the effects of proportional consolidation (CVM-247)

17


EXHIBIT II

Braskem S.A.
Consolidated Balance Sheet(1)
(R$ million)

ASSETS    09/30/2005    06/30/2005    Var. (%)
     (A)    (B)   (A)/(B)
       
Current Assets    5,238    5,949    (12)
   . Cash and Cash Equivalents    1,940    2,820    (31)
   . Account Receivable    1,440    1,297    11 
   . Inventories    1,377    1,367    1 
   . Recoverable Taxes    366    322    14 
   . Dividends/Interest attribut.to Shareholders' Equity    0    0    - 
   . Next Fiscal Year Expenses    20    33    (40)
   . Prepaid Expenses    0    0    - 
   . Others    95    109    (13)
       
Long-term Assets    1,019    971    5 
   . Related Parties    36    35    3 
   . Compulsory Deposits    151    155    (3)
   . Deferred income taxes and social contributions    266    266    0 
   . Recoverable Taxes    427    412    4 
   . Marketable Securities    34    31    9 
   . Others    104    71    47 
       
Fixed Assets    8,655    8,592    1 
   .Investments    1,307    1,321    (1)
   .Plant, property and equipment    5,133    4,982    3 
   .Deferred    2,215    2,289    (3)
       
Total Assets    14,912    15,512    (4)
       

LIABILITIES AND SHAREHOLDERS' EQUITY    09/30/2005    06/30/2005    Var. (%)
    (A)   (B)   (A)/(B)
       
Current    3,785    3,824    (1)
   . Suppliers    2,679    2,703    (1)
   . Short-term loans    796    786    1 
   . Advances on export facilities    0    0    - 
   . Salaries and social charges    86    64    35 
   . Proposed dividends/interest attributable to shareholders    2    2    0 
   . Income Tax Payable    12    15    (20)
   . Taxes payable    152    136    12 
   . Advances from Clients    18    63    (72)
   . Others    40    55    (28)
       
Long-term Liabilities    5,960    6,568    (9)
   . Related Parties    0    0    - 
   . Long-term loans    4,293    4,934    (13)
   . Taxes payable    1,362    1,339    2 
   . Others    305    295    3 
       
Deferred Income    80    81    (1)
       
Minority Interest    171    169    1 
       
Shareholders' Equity    4,916    4,869    1 
   . Capital    3,403    3,403    0 
   . Capital Reserves    392    392    0 
   . Treasury Shares    (15)   (15)   0 
   . Profit reserve    455    455    0 
   . Retained Earnings (Losses)   681    634    7 
       
Total Liabilities and Shareholders' Equity    14,912    15,512    (4)
       
1-Excludes the effects of proportional consolidation (CVM-247)

18


EXHIBIT III
Braskem S.A.
Consolidated Cash Flow(1)
(R$ million)

    3Q05    2Q05    3Q04    9M05    9M04 
Cash Flow    (A)    (B)    (C)      (E)    (D)
           
Net Income for the Period    48    428    496    681    204 
Expenses (Revenues) not affecting Cash    227    19    (8)   632    1,277 
Depreciation and Amortization    177    212    184    579    513 
 Equity Result    (4)   (45)   (49)   (77)   (64)
Interest, Monetary and Exchange Restatement, Net    32    (243)   (163)   (13)   797 
Minority Interest    (0)   (3)       17 
Others    22    99    15    142    15 
Adjusted Profit (Loss) before cash financial effects    274    447    489    1,313    1,482 
Asset and Liabilities Variation, Current and Long Term    (198)   357    329    337    257 
Asset Decutions (Additions)   (183)   173    (117)   (148)   (217)
           
                     
 Marketable Securities    (2)     (4)   (2)   30 
 Account Payable    (151)   260    (285)   (140)   (480)
 Recoverable Taxes    (58)   (66)   86    (147)   197 
 Inventories    (9)   (85)   (6)   (12)   (130)
 Advances Expenses    19      14    38    67 
 Dividends Received    43    65    39    155    83 
Other Account Receivables    (25)   (5)   34    (41)   16 
 Derivatives Fair Value           
Liabilities Additions (Reductions)   (15)   184    446    486    475 
           
                     
 Suppliers    (24)   256    360    501    715 
 Advances to Clients    (46)   11    (44)   (18)   (187)
 Fiscal Incentives      17    38    48    41 
 Taxes and Contributions      (54)   87    (20)   141 
 Other Account Receivables    49    (47)     (26)   (235)
Cash resulting from operating activities    77    804    818    1,650    1,739 
Investment Activities    (314)   (193)   (185)   (630)   (647)
 Sale fo Fixed Assets          (0)  
 Investment Allocation    (43)       (59)   (15)
 Fixed Assets Allocation    (197)   (138)   (70)   (411)   (162)
 Deferred Assets Allocation    (74)   (55)   (116)   (160)   (472)
Subsidiaries and Affiliated Companies, Net    4    (101)   (12)   (150)   (38)
Financing Activities    (647)   547    989    (648)   1,791 
 Inflows    317    1,225    2,007    1,818    5,197 
 Amortization and Paid Interest    (963)   (489)   (1,020)   (2,257)   (3,402)
 Dividend/Interest attributable to Shareholders    (0)   (189)     (209)   (4)
           
Cash and Cash Equivalents Increase (Reduction)   (880)   1,058    1,609    222    2,845 
Cash and Cash Equivalents at the beginning of period    2,820    1,763    1,775    1,718    539 
Cash and Marketable Securities at the end of period    1,940    2,820    3,384    1,940    3,384 
           
1-Excludes the effects of proportional consolidation (CVM-247)

19


EXHIBIT IV

Braskem S.A.

Consolidated Net Revenue by Business Unit(1)
(R$ million)

Business Units    3Q05    2Q05    3Q04    Var%    Var%    9M05    9M04    Var% 
(R$ milhões)   (A)   (B)   (C)   (A)/(B)   (A)/(C)   (D)   (E)   (D)/(E)
 
Domestic Market    2,258    2,273    2,595    (1)   (13)   6,910    6,421    8 
   Basic Petrochemicals    996    1,087    1,137    (8)   (12)   3,078    2,704    14 
   Polyolefins    740    683    854    8    (13)   2,232    2,118    5 
   Vynils    391    385    451    1    (13)   1,205    1,191    1 
   Business Development    131    118    154    11    (15)   395    408    (3)
 
External Market    540    612    767    (12)   (30)   1,849    1,825    1 
   Basic Petrochemicals    223    267    548    (17)   (59)   804    1,198    (33)
   Polyolefins    251    231    151    9    66    776    444    75 
   Vynils    41    80    53    (49)   (23)   185    143    30 
   Business Development    26    34    15    (24)   73    83    40    108 
 
Total Net Revenue    2,798    2,885    3,362    (3)   (17)   8,759    8,246    6 

20


SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 16, 2005

  BRASKEM S.A.
 
 
  By:      /s/      Paul Elie Altit
 
    Name: Paul Elie Altit
    Title: Chief Financial Officer